Older men with prostate cancer who are on long-term androgen deprivation therapy (ADT) often show physical performance deficits that significantly increase their risk for falls and injury, researchers report. Reuters Health Information
A meta-analysis has found that platinum-based regimens do not offer significant benefit in survival or overall tumor response, compared with second-line nonplatinum-based regimens. Medscape Medical News
Various techniques for regional chemotherapy are able to achieve 3- to 10-times higher concentrations of the cytostatic agent at the tumor than traditional chemotherapy and increased survival in patients with platinum-refractory recurrent ovarian cancer. Medscape Medical News
